A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

NCT06636656 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: BI 3032950 intravenous (Part A)
DRUG: BI 3032950 subcutaneous (Part B)

Sponsor

Boehringer Ingelheim